Mi Kyoung Seo

Prof. Mi Kyoung Seo

research professor
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JLJung Goo Lee
Jung Goo Lee
YWYoung Sup Woo
Young Sup Woo
SPSung Woo Park
Sung Woo Park
DSDae-Hyun Seog
Dae-Hyun Seog
MSMi Kyoung Seo
Mi Kyoung Seo
WBWon-Myong Bahk
Won-Myong Bahk
Melatonin is a hormone that is secreted by the pineal gland. To date, melatonin is known to regulate the sleep cycle by controlling the circadian rhythm. However, recent advances in neuroscience and molecular biology have led to the discovery of new actions and effects of melatonin. In recent studies, melatonin was shown to have antioxidant activity and, possibly, to affect the development of Alzheimer’s disease (AD). In addition, melatonin has neuroprotective effects and affects neuroplasticity, thus indicating potential antidepressant properties. In the present review, the new functions of melatonin are summarized and a therapeutic target for the development of new drugs based on the mechanism of action of melatonin is proposed.


26 April 2017 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
MSMi Kyoung Seo
Mi Kyoung Seo
CCCheol Min Choi
Cheol Min Choi
RMRoger McIntyre
Roger McIntyre
HCHye Yeon Cho
Hye Yeon Cho
CLChan Hong Lee
Chan Hong Lee
JLJung Goo Lee
Jung Goo Lee
Recent studies have suggested that the activation of mammalian target of rapamycin (mTOR) signaling may be related to antidepressant action. Therefore, the present study evaluated whether antidepressant drugs would exert differential effects on mTOR signaling in the rat hippocampus under conditions of chronic restraint stress. Male Sprague–Dawley rats were subjected to restraint stress for 6 h/days for 21 days with either escitalopram (10 mg/kg) or paroxetine (10 mg/kg) administered after the chronic stress procedure. Western blot analyses were used to assess changes in the levels of phospho-Ser2448-mTOR, phospho-Thr37/46-4E-BP-1, phospho-Thr389-p70S6 K, phospho-Ser422-eIF4B, phospho-Ser240/244-S6, phospho-Ser473-Akt, and phospho-Thr202/Tyr204-ERK in the hippocampus. Chronic restraint stress significantly decreased the levels of phospho-mTOR complex 1 (mTORC1), phospho-4E-BP-1, phospho-p70S6 K, phospho-eIF4B, phospho-S6, phospho-Akt, and phospho-ERK (p < 0.05); the administration of escitalopram and paroxetine increased the levels of all these proteins (p < 0.05 or 0.01). Additionally, chronic restraint stress reduced phospho-mTORC1 signaling activities in general, while escitalopram and paroxetine prevented these changes in phospho-mTORC1 signaling activities. These findings provide further data that contribute to understanding the possible relationships among mTOR activity, stress, and antidepressant drugs.

31 May 2022 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
JLJung Goo Lee
Jung Goo Lee
YWYoung Sup Woo
Young Sup Woo
SPSung Woo Park
Sung Woo Park
DSDae-Hyun Seog
Dae-Hyun Seog
MSMi Kyoung Seo
Mi Kyoung Seo
WBWon-Myong Bahk
Won-Myong Bahk
Jung Goo Lee, Young Sup Woo, Sung Woo Park, Dae-Hyun Seog, Mi Kyoung Seo, Won-Myong Bahk. Clin Psychopharmacol Neurosci 2022;20:228-39. https://doi.org/10.9758/cpn.2022.20.2.228

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
DHDong Hwan Ho
Dong Hwan Ho
DNDaleum Nam
Daleum Nam
MSMi Kyoung Seo
Mi Kyoung Seo
SPSung Woo Park
Sung Woo Park
WSWongi Seol
Wongi Seol
ISIlhong Son
Ilhong Son
Background. Leucine‐rich repeat kinase 2 (LRRK2) plays a critical role in the pathogenesis of Parkinson’s disease (PD). Aging is the most critical risk factor for the progression of PD. The correlation between aging and cellular senescence has been established. Cellular senescence is correlated with the dysregulation of the proteolytic pathway and mitochondrial dysfunction, which are also associated with the aggregation of α‐synuclein (α‐syn). Methods. Human dopaminergic neuron‐like cells (differentiated SH‐SY5Y cells) were treated with rotenone in the presence or absence of the LRRK2 kinase inhibitor GSK2578215A (GSK‐KI) for 48 h. The markers of cellular senescence, including p53, p21Waf1/Cip1 (p21), β‐galactosidase (β‐gal), Rb phosphorylation, senescence‐associated (SA) β‐gal activity, and lysosomal activity, were examined. The dSH cells and rat primary cortical neurons were treated with α‐syn fibrils 30 min before treatment with rotenone in the presence or absence of GSK‐KI for 48 h. Mice were intraperitoneally injected with rotenone and MLi‐2 (LRRK2 kinase inhibitor) once every two days for two weeks. Results. Rotenone upregulated LRRK2 phosphorylation and β‐gal levels through the activation of the p53‐p21 signaling axis and downregulated Rb phosphorylation. Additionally, rotenone upregulated SA β‐gal activity, reactive oxygen species levels, and LRRK2 phosphorylation and inhibited lysosome activity. Rotenone‐induced LRRK2 upregulation impaired the clearance of α‐syn fibrils. Treatment with LRRK2 inhibitor mitigated rotenone‐induced cellular senescence and α‐syn accumulation. Conclusions. Rotenone‐induced upregulation of LRRK2 kinase activity promoted cellular senescence, which enhanced α‐syn accumulation. However, the administration of an LRRK2 kinase inhibitor rejuvenated rotenone‐induced cellular senescence.

2 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
DHDong Hwan Ho
Dong Hwan Ho
DNDaleum Nam
Daleum Nam
MSMi Kyoung Seo
Mi Kyoung Seo
SPSung Woo Park
Sung Woo Park
WSWongi Seol
Wongi Seol
ISIlhong Son
Ilhong Son
Evidence suggests that crosstalk occurs between microglial leucine-rich repeat kinase 2 (LRRK2)—a regulator of neuroinflammation—and neuron-released α-synuclein (αSyn)—a promoter of microglial activation and neuroinflammatory responses—in neuroinflammation-mediated Parkinson’s disease (PD) progression. Therefore, we examined whether LRRK2 inhibition reduces the responses of microglia to neuroinflammation caused by neuron-released αSyn. We examined the neuroinflammatory responses provoked by Toll-like receptor 2 (TLR2)-positive αSyn of neuronal cells using an LRRK2 inhibitor in the mouse glioma cells, rat primary microglia, and human microglia cell line; and the effects of LRRK2 inhibitor in the co-culture of ectopic αSyn-expressing human neuroblastoma cells and human microglia cells and in mouse models by injecting αSyn. We analyzed the association between LRRK2 activity and αSyn oligomer and TLR2 levels in the substantia nigra tissues of human patients with idiopathic PD (iPD). The TLR2-specific αSyn elevated LRRK2 activity and neuroinflammation, and the LRRK2 inhibitor ameliorated neuroinflammatory responses in various microglia cells, alleviated neuronal degeneration along with neuroinflammation in the co-culture, and blocked the further progression of locomotor failure and dopaminergic neuronal degeneration caused by TLR2-specific αSyn in mice. Furthermore, LRRK2 phosphorylation was increased in patients with iPD showing αSyn-specific high TLR2 level. These results suggest the application of LRRK2 inhibitors as a novel therapeutic approach against αSyn-mediated PD progression.